Navigation Links
BMP Sunstone Announces Participation in May Investor Conferences
Date:5/16/2008

the only U.S. public company to offer industry partners a comprehensive suite of market-entry services in China that includes pre-market entry analysis, clinical trial management, product registration, market research, as well as pharmaceutical marketing and distribution. The Company provides distribution services for a wide range of products, including Western medicines, traditional Chinese medicines, bio- chemical medicines, medical applications, branded generic pharmaceuticals, over-the-counter healthcare products, and home healthcare supplies and equipments. BMP Sunstone's proprietary portfolio is currently primarily focused on women's health and pediatrics. The Company is headquartered in Plymouth Meeting, Pennsylvania.


'/>"/>
SOURCE BMP Sunstone Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. BMP Sunstone to Report First Quarter 2008 Financial Results
2. BMP Sunstones Propess(R) Recommended as First Line Treatment By the Chinese Medical Association
3. Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser
4. Tao Formulations Announces the Official Launch of Tao Harmony - Menopause Relief Formula
5. Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference
6. Anesiva Announces May 22, 2008 Presentation at Citi Investment Research Global HealthCare Conference
7. IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting
8. Tempo Participacoes Announces Increase of 34% in EBITDA and of 25% in Net Revenue for the 1Q08
9. LifeCare Holdings, Inc. Announces First Quarter Results
10. QLT Inc. announces agreement for sale of real estate
11. Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... Researchers find it prolongs lives of key vision ...thDay News) -- Researchers working with mice have ...ives of retinal cells in both healthy and diseased...eatments that would prevent blindness among people...e, the scientists said. , The protein, known as...
(Date:1/8/2009)..., BALTIMORE, Jan. 8 Physicians P...rces to help provide area physicians and their sta...artnership is a unique program designed to help do...e the cumbersome and time-consuming issues of mana...t. Mary Medical Center will use Physicians Practic...
(Date:1/8/2009)..., PORTLAND, Ore. Researchers at Oregon Health & S....edu/sod ) have discovered that the nerve cells co... a molecule known to be critically important for p...eday play a significant role in the prevention of ... pressure. According to the National Institutes of...
(Date:1/8/2009)..., SALT LAKE CITY, Jan. 8 In res...ry professionals nationwide, ARUP Laboratories, a ... in innovative laboratory research and development... the distance-learning arena, have partnered to pr...nologists (MT) and medical laboratory technicians ...
Breaking Medicine News(10 mins):Health News:Protein Might One Day Prevent Blindness 2Health News:Protein Might One Day Prevent Blindness 3Health News:Physicians Practice and St. Mary Medical Center Partner to Improve Patient Care in Long Beach, CA 2Health News:Physicians Practice and St. Mary Medical Center Partner to Improve Patient Care in Long Beach, CA 3Health News:OHSU School of Dentistry team discovers new molecule in blood-pressure control system 2Health News:ARUP Laboratories and Weber State University Team Up to Provide Laboratory Education Solutions 2Health News:ARUP Laboratories and Weber State University Team Up to Provide Laboratory Education Solutions 3Health News:ARUP Laboratories and Weber State University Team Up to Provide Laboratory Education Solutions 4
...he Bill and Melinda Gates Foundation will donate U...Development (TB Alliance) to advance a pipeline of... faster and more effective cure for the disease. S...ofit TB Alliance has built the largest pipeline in...
...he Union Government may go in for an immunisation ...ister a booster dose of measles vaccine. // Thoug...o children in state-run hospitals, the government ...ge through an additional dosage, a top official of...
...apan after a year lifts ban on poultry products fr...to the fears of an outbreak of deadly bird flu// i...e government has lifted the ban and said that the ...on June 7 said the Philippine Agriculture Secretar...
...hilippine Agriculture Secretary Domingo Panganiban...osed on the poultry is to be lifted on the 7th of ...mazaki has informed Panganiban that the Ministry o...ve found the poultry in the country free of bird f...
Other Medicine News:
(Date:1/8/2009)...PRNewswire/ -- If you are taking prescription medi...e. Half of the people taking,prescription medicin...ried -- they forget, are busy with other prioritie...ance has been called the Achilles heel of modern,... commented, "Drugs don,t,work in people who don,t...
(Date:1/7/2009).... 7 Eli Lilly and Compan... a complete response letter from,the U.S. Food an...ting,injection (LAI) for acute and maintenance tr...inuing to work with the agency on the new drug,ap... any additional clinical trials for the continued,...
(Date:1/7/2009)...7 ImQuest Life Sciences announced ...ion to the Food and Drug Administration to initiat...ione HIV inhibitor IQP-0410. ImQuest anticipates i...er of 2009. IQP-0410 is a novel small molecule inh...ide reverse transcriptase inhibitor (NNRTI). The c...
(Date:1/7/2009)...January 7 Circassia Ltd, a special...nd critical care, today,announced that following ...,its ToleroMune(R) anti-allergy technology, the co... further phase II clinical trial in cat allergy. T...ted 120 patients with confirmed,cat allergies, an...
Breaking Medicine Technology:Good Medicine: Smarter Smartphones for People With Chronic Disease 2FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 2FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 3FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 4FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 5FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Chromos Announces Full Revocation of Cease Trade Orders 6687 1Chromos Announces Full Revocation of Cease Trade Orders 6687 2Study suggests human visual system could make powerful computer 24305 1Study suggests human visual system could make powerful computer 24305 2Study suggests human visual system could make powerful computer 24305 3Study shows parasites outweigh predators 4175 1Study shows parasites outweigh predators 4175 2Study shows parasites outweigh predators 4175 3Simple Procedure Improves Male Fertility 24302 1Simple Procedure Improves Male Fertility 24302 2Simple Procedure Improves Male Fertility 24302 3
...IDGE, Mass.--(BUSINESS WIRE)--May 24, 2007 - Immun...pany that develops targeted,anticancer therapeutic...gy, today announced that clinical findings for thr...lid tumors are to be,reported at the 43rd American...g to take place June 1-5, 2007 in Chicago, IL., Tr...
...IDGE, Mass.--(BUSINESS WIRE)--May 25, 2007 - ARIAD...ced that clinical,investigators from leading cance...a from ongoing trials of the Company,s novel mTOR,...merican Society,of Clinical Oncology (ASCO) in Chi...l data from the Phase 2 trial of single-agent,AP23...
Other Medicine Technology:ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 2ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 3Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 2Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 3Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 4
The CUSA EXcel system provides tissue fragmentation, irrigation, aspiration, and the unique patented TissueSelect technology. The CUSA has been the leading ultrasonic surgical aspirator for over 25 y
SuperVu Hi-Resolution loupe provides greater definition than a standard Galilean with 15% increase field of view. The Hi-Res five element system provides a true 3x magnification in a lightweight syst
... are available in 2.8x, 4.2x and 8.25x magnificati...r supplied on a finger ring or neck cord. The 8.2...in a pocket, they are ideal for reading signposts,...spectacle mounting is the lightweight slim body 4....
The longer working distances achieved by the use of Galilean optics make this the perfect magnifier to enable the patient to read and write.
Medicine Products: